A one-pot synthesis of 6-deoxy-6-[18F]fluoro-L-ascorbic acid (18F-DFA) has been developed via nucleophilic displacement of a cyclic sulfate with no-carrier-added [18F]fluoride ion. Isolated radiochemical yields of around 15% were obtained with radiochemical purity of over 99% after overall synthesis
Radiosynthesis and preliminary biodistribution in mice of 6-deoxy-6-[131I]iodo-L-ascorbic acid
✍ Scribed by Jintaek Kim; Fumihiko Yamamoto; Satoru Karasawa; Takahiro Mukai; Minoru Maeda
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- French
- Weight
- 216 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
An ascorbate analog labeled with iodine‐131, 6‐deoxy‐ 6‐[^131^I]iodo‐L‐ascorbic acid was prepared for evaluation as an in vivo tracer of L‐ascorbic acid. The no‐carrier‐added radiosynthesis was conducted by nucleophilic bromine–iodine exchange between the brominated precursor and sodium [^131^I]iodide in 2‐pentanone at 130–140°C. HPLC purification using a reverse‐phase column gave 6‐deoxy‐6‐[^131^I]iodo‐L‐ascorbic acid in radiochemical yield of 36–60% with high radiochemical purity and satisfactory‐specific radioactivity in a total preparation time of 90 min. Biodistribution studies in fibrosarcoma‐bearing mice showed a high uptake in the adrenal glands, accompanied by low activity of tumor accumulation, accumulation properties similar to previous results obtained with ^14^C‐labeled ascorbic acid and 6‐deoxy‐6‐[^18^F]fluoro‐L‐ascorbic acid, in spite of high level of deiodination. Copyright © 2009 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract Three ^125^I‐labeled 2__‐O‐__ and 3__‐O‐m‐__iodobenzyl, and 6__‐O‐m‐__iodophenyl derivatives of L‐ascorbic acid were prepared by melt exchange procedures in isolated radiochemical yields of 12–60% after HPLC purification. Biodistribution studies in tumor‐bearing mice showed very differe